UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
For the quarterly period ended March 31, 2005
or
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
For the transition period from to
Commission file number 0-14948
FISERV, INC.
(Exact name of Registrant as specified in its charter)
WISCONSIN | 39-1506125 | |
(State or other jurisdiction of incorporation or organization) |
(I. R. S. Employer Identification No.) |
255 FISERV DRIVE, BROOKFIELD, WI | 53045 | |
(Address of principal executive office) | (Zip Code) |
(262) 879-5000
(Registrants telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by checkmark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes x No ¨
As of April 25, 2005, there were 191,289,038 shares of common stock, $.01 par value, of the Registrant outstanding.
INDEX
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended March 31, |
||||||||
2005 |
2004 |
|||||||
Revenues: |
||||||||
Processing and services |
$ | 882,319 | $ | 811,556 | ||||
Customer reimbursements |
90,795 | 97,321 | ||||||
Total revenues |
973,114 | 908,877 | ||||||
Cost of revenues: |
||||||||
Salaries, commissions and payroll related costs |
343,484 | 329,586 | ||||||
Customer reimbursement expenses |
90,795 | 97,321 | ||||||
Data processing costs and equipment rentals |
51,378 | 52,105 | ||||||
Prescription costs |
124,096 | 95,578 | ||||||
Other operating expenses |
132,322 | 127,037 | ||||||
Depreciation and amortization |
43,023 | 45,912 | ||||||
Total cost of revenues |
785,098 | 747,539 | ||||||
Operating income |
188,016 | 161,338 | ||||||
Interest expense - net |
(3,662 | ) | (4,732 | ) | ||||
Realized gain from sale of investment |
43,452 | | ||||||
Income from continuing operations before income taxes |
227,806 | 156,606 | ||||||
Income tax provision |
88,161 | 60,897 | ||||||
Income from continuing operations |
139,645 | 95,709 | ||||||
Loss from discontinued operations, net of tax |
(619 | ) | (2,911 | ) | ||||
Net income |
$ | 139,026 | $ | 92,798 | ||||
Basic net income (loss) per share: |
||||||||
Continuing operations |
$ | 0.72 | $ | 0.49 | ||||
Discontinued operations |
| (0.01 | ) | |||||
Total |
$ | 0.72 | $ | 0.48 | ||||
Diluted net income (loss) per share: |
||||||||
Continuing operations |
$ | 0.71 | $ | 0.49 | ||||
Discontinued operations |
| (0.01 | ) | |||||
Total |
$ | 0.71 | $ | 0.47 | ||||
Shares used in computing net income (loss) per share: |
||||||||
Basic |
193,383 | 194,555 | ||||||
Diluted |
195,495 | 197,063 | ||||||
See notes to condensed consolidated financial statements.
3
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
(Unaudited)
March 31, 2005 |
December 31, 2004 |
|||||||
ASSETS |
||||||||
Cash and cash equivalents |
$ | 719,728 | $ | 516,127 | ||||
Accounts receivable - net |
466,464 | 437,764 | ||||||
Prepaid expenses and other assets |
98,425 | 100,810 | ||||||
Investments |
2,589,898 | 1,984,536 | ||||||
Property and equipment - net |
196,336 | 200,709 | ||||||
Intangible assets - net |
533,371 | 532,539 | ||||||
Goodwill - net |
1,884,526 | 1,859,347 | ||||||
Assets of discontinued operations held for sale |
| 2,751,517 | ||||||
Total |
$ | 6,488,748 | $ | 8,383,349 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Accounts payable |
$ | 205,816 | $ | 202,616 | ||||
Short-term borrowings |
100,000 | 100,000 | ||||||
Accrued expenses |
278,835 | 363,513 | ||||||
Accrued income taxes |
138,033 | 44,955 | ||||||
Deferred revenues |
225,831 | 226,080 | ||||||
Customer funds held and retirement account deposits |
2,328,715 | 1,829,639 | ||||||
Deferred income taxes |
129,915 | 134,330 | ||||||
Long-term debt |
498,812 | 505,327 | ||||||
Liabilities of discontinued operations held for sale |
| 2,412,467 | ||||||
Total liabilities |
3,905,957 | 5,818,927 | ||||||
Shareholders equity: |
||||||||
Preferred stock, no par value: 25,000,000 shares authorized; none issued |
| | ||||||
Common stock issued, $0.01 par value: 450,000,000 shares authorized; 196,506,575 and 195,940,360 shares issued |
1,965 | 1,959 | ||||||
Additional paid-in capital |
695,063 | 679,573 | ||||||
Accumulated other comprehensive income (loss) |
(2,777 | ) | 26,695 | |||||
Accumulated earnings |
2,059,565 | 1,920,539 | ||||||
Treasury stock, at cost, 4,460,800 and 1,691,500 shares |
(171,025 | ) | (64,344 | ) | ||||
Total shareholders equity |
2,582,791 | 2,564,422 | ||||||
Total |
$ | 6,488,748 | $ | 8,383,349 | ||||
See notes to condensed consolidated financial statements.
4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in thousands)
(Unaudited)
Three Months Ended March 31, |
||||||||
2005 |
2004 |
|||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 139,026 | $ | 92,798 | ||||
Adjustment for discontinued operations |
619 | 2,911 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Realized gain from sale of investment |
(43,452 | ) | | |||||
Deferred income taxes |
12,068 | 28,395 | ||||||
Depreciation and amortization |
43,023 | 45,912 | ||||||
Changes in assets and liabilities, net of effects from acquisitions and dispositions of businesses: |
||||||||
Accounts receivable |
(25,774 | ) | 7,584 | |||||
Prepaid expenses and other assets |
3,874 | (8,568 | ) | |||||
Accounts payable and accrued expenses |
(46,278 | ) | (40,095 | ) | ||||
Deferred revenues |
(2,723 | ) | 5,710 | |||||
Accrued income taxes |
53,802 | 26,720 | ||||||
Net cash provided by operating activities |
134,185 | 161,367 | ||||||
Cash flows from investing activities: |
||||||||
Capital expenditures, including capitalization of software costs for external customers |
(31,772 | ) | (31,021 | ) | ||||
Payment for acquisitions of businesses, net of cash acquired |
(96,003 | ) | (29,775 | ) | ||||
Proceeds from sale of businesses, net of expenses paid |
344,920 | | ||||||
Cash distribution received from discontinued operations prior to sale |
68,000 | | ||||||
Investments |
(611,463 | ) | (351,274 | ) | ||||
Net cash used in investing activities |
(326,318 | ) | (412,070 | ) | ||||
Cash flows from financing activities: |
||||||||
Repayment of long-term debt - net |
(7,156 | ) | (106,971 | ) | ||||
Issuance of common stock |
10,495 | 11,662 | ||||||
Purchases of treasury stock |
(106,681 | ) | | |||||
Customer funds held and retirement account deposits |
499,076 | 356,073 | ||||||
Net cash provided by financing activities |
395,734 | 260,764 | ||||||
Change in cash and cash equivalents |
203,601 | 10,061 | ||||||
Beginning balance |
516,127 | 162,668 | ||||||
Ending balance |
$ | 719,728 | $ | 172,729 | ||||
See notes to condensed consolidated financial statements.
5
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Principles of Consolidation
The condensed consolidated financial statements for the three month periods ended March 31, 2005 and 2004 are unaudited. In the opinion of management, all adjustments necessary for a fair presentation of such condensed consolidated financial statements have been included. Such adjustments consisted only of normal recurring items. Interim results are not necessarily indicative of results for a full year. The financial statements and notes are presented as permitted by Form 10-Q, and do not contain certain information included in the annual consolidated financial statements and notes of Fiserv, Inc. and subsidiaries (the Company). It is recommended that these interim condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2004. Certain prior period amounts have been reclassified to conform to the current period presentation. See the Companys results by business segment in Item 2, Managements Discussion and Analysis of Financial Condition and Results of Operations.
2. Recent Accounting Pronouncement
In December 2004, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 123 (revised 2004), Share-Based Payment (SFAS 123R), that requires companies to expense the value of employee stock purchase plans, stock option grants and similar awards. In April 2005, the Securities and Exchange Commission (SEC) announced the adoption of a new rule that amends the compliance dates for SFAS 123R. The new rule allows companies to implement SFAS 123R at the beginning of their next fiscal year, instead of the next reporting period, that begins after June 15, 2005. The new rule does not change the accounting required by SFAS 123R; it only changes the date for compliance with the standard. The Company will adopt SFAS 123R on January 1, 2006 and continues to evaluate the impact that the adoption of the final standard will have on the Companys financial statements.
3. Discontinued Operations
On March 24, 2005, the Company completed the sale of its securities clearing businesses to Fidelity Global Brokerage Group, Inc. for $344.9 million paid in cash at closing, subject to certain post-closing adjustments. Prior to completion of the sale, the securities clearing businesses paid a $68.0 million cash distribution to the Company. The sales proceeds, net of related expenses, including taxes that became due upon the sale of the securities clearing businesses, approximate the Companys carrying value of its investment. The stock purchase agreement also provides for a contingent payment of up to $15.0 million to be paid after the first anniversary of the closing date based on achievement of certain revenue targets. In addition, as part of the stock purchase agreement, the Company retained the liability associated with the SEC investigation of the mutual fund trading practices of the securities clearing businesses. In April 2005, Fiserv Securities, Inc. settled with the SEC on this matter for $15.0 million which was fully accrued for in the Companys 2004 financial statements.
The Companys securities clearing businesses have been reported as discontinued operations for all periods presented and are excluded from reported revenue, cost of revenues and operating cash flows. Summarized financial information for discontinued operations included in the financial statements for the three month periods ended March 31, 2005 and 2004 was as follows:
(In thousands)
|
2005 |
2004 |
||||||
Processing and services revenues |
$ | 26,295 | $ | 28,430 | ||||
Cost of revenues |
26,713 | 32,908 | ||||||
Operating loss before income taxes |
(418 | ) | (4,478 | ) | ||||
Income tax benefit from operations |
162 | 1,567 | ||||||
Loss on sale of businesses, net of income taxes of $48,670 |
(363 | ) | | |||||
Loss from discontinued operations, net of tax |
$ | (619 | ) | $ | (2,911 | ) | ||
4. Long-Term Debt
The Company has a credit facility totaling $700.0 million, which is comprised of a $465.3 million five-year revolving credit facility due in 2009 and a $234.7 million 364-day revolving credit facility that is renewable annually through 2009. The Company must, among other requirements, maintain a minimum net worth of $1.9 billion as of March 31, 2005 and limit its total debt to no more than three and one-half times the Companys earnings before interest, taxes, depreciation and amortization. The Company was in compliance with all debt covenants at March 31, 2005.
6
5. Stock-Based Compensation
The Company has accounted for its stock-based compensation plans in accordance with the intrinsic value provisions of Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees. Accordingly, the Company did not record compensation expense in the condensed consolidated financial statements for its stock-based compensation plans.
The following table illustrates the effect on net income and net income per share had compensation expense been recognized consistent with the fair value provisions of SFAS No. 123, Accounting for Stock-Based Compensation (SFAS 123). The fair value of each option issued prior to January 1, 2004 was estimated on the date of grant using a Black-Scholes option-pricing model. For options granted on or after January 1, 2004, the fair value of each option was estimated on the date of grant using a binomial option-pricing model. Stock options are typically granted in the first quarter of the year, generally vest 20% on the date of grant and 20% each year thereafter and expire 10 years from the date of the award. As a result, the expense that would be recognized under SFAS 123 during the first quarter is significantly higher than the expense for the remaining quarters. The calculated expense for the first quarter of 2005 was higher than 2004 as certain participants met accelerated vesting provisions stipulated in the stock option agreements related to age and years of service with the Company. In 2005, the first quarter pro forma after-tax stock compensation expense of $11.0 million should approximate 55% of the full year 2005 expense.
Three months ended March 31, |
||||||||
(In thousands, except per share data)
|
2005 |
2004 |
||||||
Net income: |
||||||||
As reported |
$ | 139,026 | $ | 92,798 | ||||
Less: stock compensation expense - net of tax |
(11,000 | ) | (5,500 | ) | ||||
Pro forma |
$ | 128,026 | $ | 87,298 | ||||
Reported net income per share: |
||||||||
Basic |
$ | 0.72 | $ | 0.48 | ||||
Diluted |
0.71 | 0.47 | ||||||
Pro forma net income per share: |
||||||||
Basic |
$ | 0.66 | $ | 0.45 | ||||
Diluted |
0.65 | 0.44 |
6. Shares Used in Computing Net Income Per Share
The computation of the number of shares used in calculating basic and diluted net income per share was as follows:
Three months ended March 31, | ||||
(In thousands)
|
2005 |
2004 | ||
Weighted-average shares outstanding used for calculation of net income per share-basic |
193,383 | 194,555 | ||
Common stock equivalents |
2,112 | 2,508 | ||
Total shares used for calculation of net income per share-diluted |
195,495 | 197,063 | ||
Weighted-average shares under stock options excluded from the calculation of common stock equivalents as the impact was anti-dilutive |
2,300 | 1,900 | ||
7. Comprehensive Income
Comprehensive income consists of net income, changes in unrealized gains and losses on available-for-sale investment securities, foreign currency translation and fair market value adjustments on cash flow hedges. Comprehensive income for the three month periods ended March 31, 2005 and 2004 was $109.6 million and $95.8 million, respectively. Compared to net income, comprehensive income for the three month period ended March 31, 2005 was negatively impacted by the realized gain on the sale of the Companys remaining ownership of 3.2 million shares of Bisys Group, Inc. common stock.
7
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Results of Operations
The Company is an independent provider of financial data processing systems and related information management services and products to financial institutions, other financial intermediaries and employers who self-insure their health plans. The Companys continuing operations are classified into three business segments: Financial institution outsourcing, systems and services (Financial); Health plan management services (Health); and Investment support services (Investment).
The following tables and discussion exclude the revenues and expenses associated with customer reimbursements because management believes that it is not appropriate to include customer reimbursements in analyzing the current performance of the Company as these balances offset in revenues and expenses with no impact on operating income and these amounts are not an indicator of current or future business trends. Customer reimbursements, which primarily consist of pass-through expenses such as postage and data communication costs, were $90.8 million and $97.3 million for the three month periods ended March 31, 2005 and 2004, respectively. The following table presents, for the periods indicated, certain amounts included in the Companys condensed consolidated statements of income, the relative percentage that those amounts represent to processing and services revenues, and the change in those amounts from period to period.
Three months ended (In millions) |
Percentage of revenues Three months ended March 31, |
Increase (Decrease) |
|||||||||||||||||
2005 |
2004 |
2005 |
2004 |
In millions |
Percentage |
||||||||||||||
Processing and services revenues: |
|||||||||||||||||||
Financial |
$ | 608.5 | $ | 574.5 | 69 | % | 71 | % | $ | 34.0 | 6 | % | |||||||
Health |
241.1 | 206.6 | 27 | % | 25 | % | 34.5 | 17 | % | ||||||||||
Investment |
32.7 | 30.5 | 4 | % | 4 | % | 2.3 | 8 | % | ||||||||||
Total |
$ | 882.3 | $ | 811.6 | 100 | % | 100 | % | $ | 70.8 | 9 | % | |||||||
Cost of revenues: |
|||||||||||||||||||
Salaries, commissions and payroll related costs |
$ | 343.5 | $ | 329.6 | 39 | % | 41 | % | $ | 13.9 | 4 | % | |||||||
Data processing costs and equipment rentals |
51.4 | 52.1 | 6 | % | 6 | % | (0.7 | ) | (1 | )% | |||||||||
Prescription costs |
124.1 | 95.6 | 14 | % | 12 | % | 28.5 | 30 | % | ||||||||||
Other operating expenses |
132.3 | 127.0 | 15 | % | 16 | % | 5.3 | 4 | % | ||||||||||
Depreciation and amortization |
43.0 | 45.9 | 5 | % | 6 | % | (2.9 | ) | (6 | )% | |||||||||
Total |
$ | 694.3 | $ | 650.2 | 79 | % | 80 | % | $ | 44.1 | 7 | % | |||||||
Operating income: (1) |
|||||||||||||||||||
Financial |
$ | 160.1 | $ | 138.5 | 26 | % | 24 | % | $ | 21.6 | 16 | % | |||||||
Health |
22.3 | 18.7 | 9 | % | 9 | % | 3.6 | 19 | % | ||||||||||
Investment |
5.6 | 4.1 | 17 | % | 14 | % | 1.5 | 35 | % | ||||||||||
Total |
$ | 188.0 | $ | 161.3 | 21 | % | 20 | % | $ | 26.7 | 17 | % | |||||||
(1) | Operating margin by segment is calculated as a percentage of each segments processing and services revenues. |
Internal Revenue Growth
Internal revenue growth percentages are measured as the increase or decrease in total processing and services revenues for the current period less acquired revenue from acquisitions divided by total processing and services revenues from the prior year period plus acquired revenue from acquisitions. Acquired revenue from acquisitions represents pre-acquisition normalized revenue of acquired companies, less dispositions, for the comparable prior year period. Internal revenue growth percentage is a non-GAAP financial measure that the Company believes is useful to investors because it provides a breakdown of internal and acquisition-related revenue growth. The following table sets forth the calculation of internal revenue growth for the three months ended March 31, 2005:
(In millions) |
Three months ended March 31, |
|||||||||||||||
2005 |
2004 |
Increase (Decrease) |
2005 Internal |
2004 Internal |
||||||||||||
Total Company |
||||||||||||||||
Processing and services revenues |
$ | 882.3 | $ | 811.6 | $ | 70.8 | ||||||||||
Acquired revenue from acquisitions |
10.1 | (10.1 | ) | |||||||||||||
Adjusted revenues |
$ | 882.3 | $ | 821.7 | $ | 60.7 | 7 | % | 10 | % | ||||||
By Segment: |
||||||||||||||||
Financial |
||||||||||||||||
Processing and services revenues |
$ | 608.5 | $ | 574.5 | $ | 34.0 | ||||||||||
Acquired revenue from acquisitions |
4.9 | (4.9 | ) | |||||||||||||
Adjusted revenues |
$ | 608.5 | $ | 579.4 | $ | 29.1 | 5 | % | 2 | % | ||||||
Health |
||||||||||||||||
Processing and services revenues |
$ | 241.1 | $ | 206.6 | $ | 34.5 | ||||||||||
Acquired revenue from acquisitions |
5.2 | (5.2 | ) | |||||||||||||
Adjusted revenues |
$ | 241.1 | $ | 211.8 | $ | 29.3 | 14 | % | 41 | % | ||||||
Investment |
||||||||||||||||
Processing and services revenues |
$ | 32.7 | $ | 30.5 | $ | 2.3 | 8 | % | (2 | )% | ||||||
8
Processing and Services Revenues
Total processing and services revenues increased $70.8 million, or 9%, in the first quarter of 2005 compared to the first quarter of 2004. Internal revenue growth for the first quarter was 7% in 2005 and 10% in 2004 and the decrease in the Companys internal revenue growth rate in 2005 was primarily due to lower revenue growth in the Health segment. Overall internal revenue growth in 2005 was primarily derived from sales to new clients, cross-sales to existing clients and increases in transaction volumes from existing clients.
The Financial segment had positive revenue growth of $34.0 million, or 6%, in the first quarter of 2005 compared to the first quarter of 2004. The internal revenue growth rate in the Financial segment was 5% in 2005 and 2% in 2004, with the remaining growth resulting from acquisitions. The increase in internal revenue growth rates in 2005 was primarily due to increased sales in the segments core financial institution software products and service bureau businesses, increases in volumes in the mortgage processing and loan settlement services businesses and increases in the flood insurance processing business which has experienced high levels of claims processing in the first quarter of 2005.
In addition, the Financial segment revenues include early contract termination fees of $14.9 million for the first quarter of 2005, primarily from 6 clients that were acquired by other financial institutions, compared to $14.3 million for the first quarter of 2004 primarily from 2 clients that were acquired by other financial institutions. This segments businesses generally enter into three to five-year contracts with its clients that contain early contract termination fees. These fees can vary significantly from period to period based on the number of terminated contracts and how early in the contract term a contract is terminated.
The Health segment had positive revenue growth of $34.5 million, or 17%, in the first quarter of 2005 compared to the first quarter of 2004. Internal revenue growth in this segment was 14% in 2005 (10% due to the inclusion in revenues and cost of revenues of prescription ingredient costs) compared to 41% in 2004 (31% due to the inclusion in revenues and cost of revenues of prescription ingredient costs). The lower overall internal revenue growth rate in 2005 compared to 2004 was primarily due to the signing of several large customers in early 2004 and lower than historical growth rates in volumes from existing clients in the pharmacy services businesses during 2005.
The Investment segment had positive revenue growth of $2.3 million, or 8%, in the first quarter of 2005 compared to the first quarter of 2004. The internal revenue growth rate of 8% in 2005 in this segment was primarily due to new customer sales, increased assets under administration which have improved trust administration fee income and a combination of increased investments and rising interest rates which increased investment income.
Cost of Revenues
Total cost of revenues increased $44.1 million, or 7%, in the first quarter of 2005 compared to the first quarter of 2004. As a percent of processing and services revenues, cost of revenues was 79% in the first quarter of 2005 and 80% in the first quarter of 2004. As a percentage of revenues, salaries, commissions and payroll related costs and other operating expenses decreased and prescription costs increased compared to the prior year due primarily to continued growth in the Health segments pharmacy services businesses. The pharmacy services businesses have a very high proportion of total costs related to the prescription cost which increased by $28.5 million in the first quarter of 2005 from 2004 as a result of increased revenues.
Operating Income
Operating income increased $26.7 million, or 17%, in the first quarter of 2005 compared to the first quarter of 2004 primarily due to an operating income increase of $21.6 million, or 16%, in the Financial segment. Operating margins in the Financial segment were 26% in the first quarter of 2005 and 24% in the first quarter of 2004. The increase in operating margins was primarily driven by continuing cost synergies in the Companys existing operations from product consolidations and higher flood claims processing and higher sales of core financial institution software to new customers which generate higher incremental margins. Operating margins in the first quarter of 2005 and 2004 were both positively impacted by a similar amount of contract termination fees as discussed above.
The Health segment increased operating income $3.6 million, or 19%, in the first quarter of 2005 compared to the first quarter of 2004, with the operating margin remaining at 9% in both 2005 and 2004.
The Investment segment increased operating income $1.5 million, or 35%, in the first quarter of 2005 compared to the first quarter of 2004. Operating margins in the Investment segment were 17% for the first quarter of 2005 and 14% in the first quarter of 2004. The increase in operating margin was primarily due to the impact of rising interest rates and investment balances as discussed above and was also positively impacted by lower costs resulting from the completion of its consolidation onto one technology platform and into one location during 2004.
Discontinued Operations
On March 24, 2005, the Company completed the sale of its securities clearing businesses to Fidelity Global Brokerage Group, Inc. for $344.9 million paid in cash at closing, subject to certain post-closing adjustments. Prior to completion of the sale, the securities clearing businesses paid a $68.0 million cash distribution to the Company. The sales proceeds, net of related expenses, including taxes that became due upon the sale of the securities clearing businesses, approximate the Companys carrying value of its investment. The Company recorded a net loss on the sale of discontinued operations of $0.4 million, net of related income taxes of $48.7 million. The higher income tax expense on the sale of the securities clearing operations was primarily due to a significantly lower tax basis than book basis in the discontinued operations due primarily to a tax free exchange in the Companys initial purchase of one of the companies included in discontinued operations. The stock purchase agreement also provides for a contingent payment of up to $15.0 million to be paid after the first anniversary of the closing date based on achievement of certain revenue targets. In addition, as part of the stock purchase agreement, the Company retained the liability associated with the Securities and Exchange Commissions (SEC) investigation of the mutual fund trading practices of the securities clearing businesses. In April 2005, Fiserv Securities, Inc. settled with the SEC on this matter for $15.0 million which was fully accrued for in the Companys 2004 financial statements.
Realized Gain from Sale of Investment
During the quarter ended March 31, 2005, the Company recorded a one-time realized gain of $43.5 million, or $0.14 per share, from the sale of its remaining ownership of 3.2 million shares of Bisys Group, Inc. common stock.
9
Income Tax Provision
The effective income tax rate on continuing operations was 38.7% in the first quarter of 2005 and 38.9% in the first quarter of 2004.
Net Income Per Share - Diluted
Net income per share-diluted was $0.71 in the first quarter of 2005 compared to $0.47 in the first quarter of 2004. The $0.71 in net income for the first quarter of 2005 was positively impacted by $0.14 per share due to a one-time realized gain on the sale of the 3.2 million shares of Bisys Group, Inc. common stock.
Liquidity and Capital Resources
Free cash flow is measured as net cash provided by operating activities less capital expenditures including capitalization of software costs for external customers, as reported in the Companys condensed consolidated statements of cash flows. Free cash flow is a non-GAAP financial measure that the Company believes is useful to investors because it provides another measure of available cash flow after the Company has satisfied the capital requirements of its operations. The following table summarizes free cash flow for the Company:
Three months ended March 31, |
||||||||
(In millions) | 2005 |
2004 |
||||||
Net cash provided by operating activities |
$ | 134.2 | $ | 161.4 | ||||
Capital expenditures, including capitalization of software costs for external customers |
(31.8 | ) | (31.0 | ) | ||||
Free cash flow |
$ | 102.4 | $ | 130.3 | ||||
Free cash flow in the first quarter of 2005 was $102.4 million, decreasing $27.9 million over the prior year period. The decrease was primarily due to an increase in accounts receivable of $25.8 million in 2005, or 6%, which is primarily due to increased internal revenue growth in the Financial segment and the timing of accounts receivable collections. The free cash flow in both years was negatively impacted by the Companys annual 401(k) contributions of approximately $40 million in the first quarters of 2005 and 2004. In addition, gross software development costs for external customers capitalized in the first three months of 2005 were $11.9 million, offset by associated amortization of $11.9 million.
The Company received a $68.0 million cash distribution from the discontinued securities clearing businesses prior to the sale and received $344.9 million in proceeds from the sale of the Companys securities clearing businesses. During the quarter ended March 31, 2005, the Company also made payments of $96.0 million related to the acquisition of a business and contingent payments on previous acquisitions.
The Company has a credit facility totaling $700.0 million, which is comprised of a $465.3 million five-year revolving credit facility due in 2009 and a $234.7 million 364-day revolving credit facility that is renewable annually through 2009. Long-term debt includes $191.7 million borrowed under the credit facility at March 31, 2005. The Company must, among other requirements, maintain a minimum net worth of $1.9 billion as of March 31, 2005 and limit its total debt to no more than three and one-half times the Companys earnings before interest, taxes, depreciation and amortization. At March 31, 2005, the Company had $498.8 million of long-term debt, while shareholders equity was $2.6 billion. The Company was in compliance with all debt covenants at March 31, 2005.
The Company believes that its cash flow from operations together with its existing cash balances will be adequate to meet its operating requirements. In the event the Company makes significant future acquisitions, however, it may raise funds through additional borrowings or the issuance of securities.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
Certain matters discussed herein are forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified as such because the context of the statement will include words such as believes, anticipates, or expects, or words of similar import. Similarly, statements that describe future plans, objectives or goals of the Company are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, which could cause actual results to differ materially from those currently anticipated. Factors that could affect results include, among others, economic, competitive, governmental, regulatory and technological factors affecting the Companys operations, markets, services and related products, prices and other factors discussed in the Companys prior filings with the Securities and Exchange Commission. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The Company assumes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Companys quantitative and qualitative disclosures about market risk are incorporated by reference to Item 7A of the Companys Annual Report on Form 10-K for the year ended December 31, 2004 and have not materially changed since that report was filed.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of disclosure controls and procedures.
As required by Rule 13a-15(b) under the Securities Exchange Act of 1934 (the Exchange Act), management, with the participation of the Companys chief executive officer and chief financial officer, evaluated the design and operation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, the Companys chief executive officer and chief financial officer concluded that the Companys disclosure controls and procedures were effective as of March 31, 2005.
Changes in internal controls over financial reporting.
There was no change in the Companys internal control over financial reporting that occurred during the quarter ended March 31, 2005 that has materially affected, or is reasonably likely to materially affect, the Companys internal control over financial reporting.
10
In April 2005, without admitting or denying the findings of the Securities and Exchange Commission (SEC), Fiserv Securities, Inc. (FSI) consented to an SEC order censuring FSI, requiring it to pay disgorgement in the amount of $5 million and a civil penalty in the amount of $10 million and requiring FSI to comply with certain undertakings. The aggregate $15 million required to be paid to the SEC was fully accrued for in the Companys 2004 financial statements. The Company sold FSI in March 2005.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The table below sets forth information with respect to purchases made by or on behalf of the Company or any affiliated purchaser (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934) of shares of Company common stock during the three months ended March 31, 2005:
Period |
Total Number of Shares Purchased |
Average Price Paid per Share |
Total Number of Shares Purchased as Part of Publicly Plans or Programs (1) |
Maximum Number of Shares that May Yet Be Purchased Under the Plans or | |||||
January 1 - 31, 2005 |
739,300 | $ | 39.39 | 739,300 | 7,545,230 | ||||
February 1 - 28, 2005 |
700,000 | $ | 37.94 | 700,000 | 6,845,230 | ||||
March 1 - 31, 2005 |
1,330,000 | $ | 38.35 | 1,330,000 | 5,515,230 | ||||
Total |
2,769,300 | $ | 38.52 | 2,769,300 | |||||
(1) | In 2004, the Companys Board of Directors authorized the repurchase of 8.3 million shares of the Companys common stock. As of March 31, 2005, 5,515,230 shares remained authorized for purchase under that program. The repurchase authorization does not expire. |
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
At the Companys Annual Meeting of Shareholders held on April 6, 2005, the Companys shareholders approved the following matters:
For |
Withheld | |||
1. ELECTION OF THREE DIRECTORS TO SERVE |
||||
FOR A THREE-YEAR TERM EXPIRING IN 2008: |
||||
Donald F. Dillon |
172,623,726 | 6,115,919 | ||
Gerald J. Levy |
172,078,372 | 6,661,273 | ||
Glenn M. Renwick |
174,511,813 | 4,227,832 |
The other directors of the Company whose terms in office continued after the 2005 Annual Meeting of Shareholders are as follows: terms expiring at the 2006 Annual Meeting - Daniel P. Kearney, Leslie M. Muma and L. William Seidman; and terms expiring at the 2007 Annual Meeting - Kenneth R. Jensen, Kim M. Robak and Thomas C. Wertheimer.
For |
Against |
Abstain |
||||||
2. RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR 2005. |
172,537,957 | 5,027,263 | 1,174,425 | |||||
For |
Against |
Abstain |
Non-Vote | |||||
3. APPROVE THE COMPANYS EXECUTIVE INCENTIVE COMPENSATION PLAN, AS AMENDED AND RESTATED |
147,252,864 | 3,475,453 | 1,731,515 | 26,279,813 | ||||
For |
Against |
Abstain |
Non-Vote | |||||
4. APPROVE THE COMPANYS STOCK OPTION AND RESTRICTED STOCK PLAN, AS AMENDED AND RESTATED |
142,145,290 | 8,661,082 | 1,653,460 | 26,279,813 |
11
The exhibits listed in the accompanying exhibit index are filed as part of this Quarterly Report on Form 10-Q.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Fiserv, Inc. | ||||
(Registrant) | ||||
Date: April 29, 2005 |
By: | /s/ Kenneth R. Jensen | ||
KENNETH R. JENSEN | ||||
Senior Executive Vice President, Chief | ||||
Financial Officer, Treasurer and Assistant | ||||
Secretary |
12
Exhibit Number |
Exhibit Description | |
10.1 | Form of Employee Restricted Stock Agreement (filed as Exhibit 10.1 to the Companys Current Report on Form 8-K | |
filed on March 31, 2005 and incorporated herein by reference (File No. 000-14948)) | ||
31.1 | Certification of the Chief Executive Officer, dated April 29, 2005 | |
31.2 | Certification of the Chief Financial Officer, dated April 29, 2005 | |
32 | Certification of the Chief Executive Officer and Chief Financial Officer, dated April 29, 2005 |
13